We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current QBIO market cap is 72.55k. The company's latest EPS is USD -0.0241 and P/E is 0.00.
| Year End November 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 30k | 196k | 284k |
| Operating Income | -9.02M | -8.02M | -13.15M | -7.39M | -3.45M |
| Net Income | -9.27M | -10.28M | -14.35M | -8.74M | -3.49M |
| Year End November 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.2M | 640k | 623k | 809k | 3.52M |
| Total Liabilities | 3.3M | 5.69M | 1.7M | 5.49M | 8.13M |
| Total Equity | -106k | -5.05M | -1.08M | -4.69M | -4.62M |
| Year End November 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.45M | -4.11M | -6.23M | -4.3M | 1.94M |
| Investing | -500k | N/A | N/A | N/A | -3.14M |
| Financing | 8.81M | 1.59M | 6.24M | 4.47M | 908k |
| Market Cap | 72.55k |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 145.09M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 1.79k |
| 52 Week Change | -96.21% |
| 52 Week High | 0.0155 |
| 52 Week Low | 0.000001 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Q BioMed Inc (CE) |
| Address |
701 s. carson street carson city, nevada 89701 |
| Website | https://www.qbiomed.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
